transactions exceeding $12 billion in total value.
In a recent deal, Frankle advised Sapheon Inc., a privately-held developer of venous
disease treatments, in its acquisition by Covidien PLC.
"One of the reasons that transaction was fun was, Covidien, in the midst of our negotiation,
while we ...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In